Meritage Portfolio Management Regeneron Pharmaceuticals, Inc. Transaction History

Meritage Portfolio Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 01, 2023	BUY	$705.89 - $766.39 $5,647 - $6,131	8 Added 1.36%	595 $429,000
Q3 2022 Oct 25, 2022	BUY	$573.97 - $724.32 $336,920 - $425,175	587 New	587 $404,000
Q2 2022 Jul 25, 2022	SELL	$548.35 - $738.84 $9.18 Million - $12.4 Million	-16,733 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$595.12 - $698.43 $9.96 Million - $11.7 Million	16,733 New	16,733 $11.7 Million
Q3 2020 Oct 26, 2020	SELL	$544.75 - $658.21 $5.49 Million - $6.64 Million	-10,082 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$493.32 - $643.92 $4.97 Million - $6.49 Million	10,082 New	10,082 $6.29 Million

1,516

82.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $73.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Meritage Portfolio Management, based on Form 13F filings with the SEC.

Stay updated on Meritage Portfolio Management with notifications on news.